EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Advances in natural product-based nanoparticles for the treatment of acute lung injury

Yunfeng Zheng, Yuting Zhao, Shuo Zhang, Min Wang, Xianwen Wang, Xu-Lin Chen

Materials Today Bio · 2025-12 · 35 · 102486

DOI: 10.1016/j.mtbio.2025.102486 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Materials Today Bio, 2025-12. Verfasst von Yunfeng Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burns, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Anhui Provincial Key Research and Development Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lung injury (ALI) is a rapid-onset inflammatory pathology in pulmonary tissue induced by multiple causative agents. ALI usually develops rapidly within hours to days after an acute episode, and despite the development of aggressive therapeutic measures, the prognosis of patients with ALI remains poor. Currently, the clinical treatment of ALI is based on supportive therapy, and with the advancement of technology, many natural products have been used for the treatment of ALI because of their advantages, such as lower drug resistance and more abundant sources; however, shortcomings such as its lower targeting limit its further clinical application. The use of nanotechnology may be an effective way to address these issues. The combination of natural products and nanotechnology offers the possibility of solving the problems of their low bioavailability and poor water solubility, which is expected to promote their application in the field of ALI therapy. Natural product-based nanomaterials can control the progression of ALI through mechanisms such as modulating immune responses and reducing tissue inflammation. This review focuses on the roles of natural product-based nanoparticles in the treatment of ALI and further elaborates on the problems and challenges faced by natural product-based nanoparticles in the effective clinical treatment of ALI.

Schlagwörter

Stichwörter der Autor:innen

Acute lung injuryNanoparticlesNanotechnologyNatural productTargeted treatment

Autor:innen und Institutionen

  • Department of Burns, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
  • School of Biomedical Engineering, Anhui Medical University, Hefei, 230022, China.

Förderung

  • National Natural Science Foundation of China
  • Anhui Provincial Key Research and Development Plan

Zitieren

APA

Zheng, Y., Zhao, Y., Zhang, S., Wang, M., Wang, X., & Chen, X. L. (2025). Advances in natural product-based nanoparticles for the treatment of acute lung injury. Materials Today Bio, 35, 102486. https://doi.org/10.1016/j.mtbio.2025.102486

Vancouver

Zheng Y, Zhao Y, Zhang S, Wang M, Wang X, Chen XL. Advances in natural product-based nanoparticles for the treatment of acute lung injury. Materials Today Bio. 2025;35:102486. doi:10.1016/j.mtbio.2025.102486

BibTeX
@article{Zheng2025,
  author = {Zheng, Yunfeng and Zhao, Yuting and Zhang, Shuo and Wang, Min and Wang, Xianwen and Chen, Xu-Lin},
  title = {Advances in natural product-based nanoparticles for the treatment of acute lung injury},
  journal = {Materials Today Bio},
  year = {2025},
  volume = {35},
  pages = {102486},
  doi = {10.1016/j.mtbio.2025.102486}
}
Kostenlos starten →